Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
Completed
- Conditions
- FatigueHodgkin Lymphoma
- First Posted Date
- 2010-10-26
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 10
- Registration Number
- NCT01228461
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients
Phase 1
Completed
- Conditions
- Pediatric Patients With Acute Lymphoblastic Leukemia
- Interventions
- Drug: High-dose trivalent inactivated influenza vaccineDrug: Standard dose trivalent inactivated influenza vaccine
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2019-05-03
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 50
- Registration Number
- NCT01216332
- Locations
- 🇺🇸
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
Inhaled Iloprost in Mild Asthma
Early Phase 1
Completed
- Conditions
- Asthma
- First Posted Date
- 2010-09-27
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 24
- Registration Number
- NCT01209533
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
Completed
- Conditions
- Gastroesophageal Reflux Disease
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 254
- Registration Number
- NCT01204931
- Locations
- 🇺🇸
Vanderbilt University Medical Center GI Outpatient Clinic, Nashville, Tennessee, United States
Cell Mediated Immunity in Older Adults
Not Applicable
Completed
- Conditions
- Immunity to Influenza Vaccine
- Interventions
- Biological: fluzone by sanofi pasteurBiological: High dose influenza vaccine Sanofi-Pasteur
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2014-04-24
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 105
- Registration Number
- NCT01189123
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
Completed
- Conditions
- FibrosisBiomarkersLymphedemaPolymorphism, GeneticHead and Neck NeoplasmsDepression
- First Posted Date
- 2010-08-23
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 100
- Registration Number
- NCT01187173
- Locations
- 🇺🇸
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
Smoking Cessation Invention in the Emergency Department (ED)
Not Applicable
Completed
- Conditions
- Smoking CessationTobacco Use CessationHealth Behavior
- Interventions
- Other: Smoking Cessation
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2012-12-27
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 199
- Registration Number
- NCT01173653
- Locations
- 🇺🇸
Vanderbilt University Medical Center - Emergency Medicine, Nashville, Tennessee, United States
Factors Involved in Obesity-related Inflammation and Insulin Resistance
Terminated
- Conditions
- InflammationObesityInsulin Resistance
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 62
- Registration Number
- NCT01173705
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis
Phase 1
Completed
- Conditions
- Pulmonary SarcoidosisLung Function
- Interventions
- Drug: levaquin; ethambutol; rifampin and azithromycin.
- First Posted Date
- 2010-07-23
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 15
- Registration Number
- NCT01169038
- Locations
- 🇺🇸
Vanderbilt University School of Medicine, Nashville, Tennessee, United States
Topical Silver for Prevention of Wound Infection After Cesarean Delivery
Not Applicable
Terminated
- Conditions
- Wound Infection
- Interventions
- Device: Cloth adhesive dressingDevice: Silver-containing surgical dressing
- First Posted Date
- 2010-07-23
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 475
- Registration Number
- NCT01169064
- Locations
- 🇺🇸
Vanderbilt University Hospital, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath